Martina Štampar a, Bojana Žegura a a National Institute of Biology, Department of Genetic Toxicology and Cancer Biology, 1000 Ljubljana, Slovenia Read more
Read articleDuring 2024 EEMGS and ICAW congress in Rovinj, Croatia, researchers from National Institute of Biology presented CutCancer project in the form of poster. ŠTERN, Alja, BREZNIK, Barbara, NOVAK, Metka, DOAK Shareen Heather, VAN MALDEGEM, Febe, NILSSON Mats, ŽEGURA, Bojana, EEMGS Annual Meeting and ICAW meeting, 23.-27 Sep. 2024, Rovinj. CutCancer : a twinning approach to…
Read articleDuring 2024 EEMGS and ICAW congress in Rovinj, Croatia, researchers from National Institute of Biology presented their CutCancer related work as a posters. KOLOŠA, Katja, ŠTERN, Alja, ŽABKAR, Sonja, ROZMAN, Iza, ŽEGURA, Bojana, et al., EEMGS Annual Meeting and ICAW meeting, 23.-27 Sep. 2024, Rovinj. Genotoxicity assessment of Vanadium-doped iron-oxide nanozymes in HepG2 cells. Arhiv…
Read articleTim Ravnjak, PhD student from NIB, attended EUSAAT 2024 congress in Linz, Austria and presented his work, titled: HepG2 spheroids: a new testing approach for the determination of adverse effects of chemicals as a poster. Abstract: RAVNJAK, Tim, ŠTAMPAR, Martina, AUDEBERT, Marc, ŽEGURA, Bojana. HepG2 spheroids : a new testing approach for the determination of…
Read articlehttps://doi.org/10.1016/j.biopha.2024.116969 Alja Štern, Matjaž Novak, Katja Kološa, Jurij Trontelj, Sonja Žabkar, Tjaša Šentjurc, Metka Filipič, Bojana ŽeguraCannabidiol (CBD), a naturally occurring cyclic terpenoid found in Cannabis sativa L., is renowned for its diverse pharmacological benefits. Marketed as a remedy for various health issues, CBD products are utilized by patients as a supplementary therapy or post-treatment failure, as well as by…
Read articleOpen access: https://doi.org/10.1016/j.isci.2024.110604 Bernarda Majc, Anamarija Habič, Marta Malavolta, Miloš Vittori, Andrej Porčnik, Roman Bošnjak, Jernej Mlakar, Alenka Matjašič, Andrej Zupan, Marija Skoblar Vidmar, Tamara Lah Turnšek, Aleksander Sadikov, Barbara Breznik, Metka Novak Glioblastoma (GB) is the most common primary malignant brain tumor, characterized by resistance to therapy. Despite aggressive treatment options, GB remains an…
Read article
Barbara Breznik presented research work at the EACR congress in Rotterdam (10-13 June) in a form of poster presentation. She presented work, entitled »Utilizing translational platform GlioBank to identify novel molecular signatures of glioblastoma progression«. Glioblastoma (GBM) is one of the most lethal solid tumors in humans. Currently, GBM is considered incurable and there is…
Read article
Air Protection 2023, Mlini, Dubrovnik, Croatia NOVAK, Matjaž, KOLOŠA, Katja, ROZMAN, Iza, ŠENTJURC, Tjaša, ŽEGURA, Bojana https://huzz.hr/Zbornik/Zbornik_sazetaka_za_web.pdf
Read article
EUROTOX2023, Ljubljana, Slovenia ŠTERN, Alja, ŽABKAR, Sonja M., ROZMAN, Iza, SÁENZ HERNÁNDEZ, A., MORENO-MALDONADO, A. C., FUENTES, J. A., GOYA, G. F., ŽEGURA, Bojana https://cdn2.me-qr.com/pdf/17475359.pdf
Read articleIn May, Brain tumour meeting 2024 was held in Berlin. It was a brilliant event with great talks about brain cancer cell’ plasticity, brain metastases, tumour microenvironment, and the role of immune system in brain tumours. We are proud of PhD student Tina Kolenc Milavec, a member of our group, who attended the meeting with…
Read article